+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Sterile Injectable Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 99 Pages
  • January 2025
  • Region: Global
  • Prof Research
  • ID: 5865549
The sterile injectable market is witnessing substantial growth, fueled by increasing demand for safe and effective drug delivery systems across healthcare facilities such as hospitals and clinics. Rising prevalence of chronic diseases, advancements in biologics, and the growing adoption of sterile injectables in treatment protocols are key drivers of market expansion. Regulatory support for injectable drugs and improvements in manufacturing processes are further contributing to the market's development.

Market Size

The sterile injectable market is projected to grow at a compound annual growth rate (CAGR) of 5.5% to 7.0% during the forecast period, driven by rising healthcare spending and increased demand for both small and large molecule injectable drugs.

Market Share & Trends Analysis

By Product Type

  • Small Molecules: This segment holds a significant share of the market, driven by the widespread use of small-molecule sterile injectables in the treatment of various chronic diseases. The segment is expected to grow at a CAGR of 5.0% to 6.5%.
  • Large Molecules: The increasing adoption of biologics and biosimilars is driving growth in the large molecule segment. This segment is projected to expand at a CAGR of 6.5% to 8.0% over the forecast period.

By Application

  • Hospitals: Hospitals are the largest application segment, accounting for an estimated 60% to 70% of the market share. This segment is expected to grow at a CAGR of 6.0% to 7.5%, supported by the rising number of in-patient treatments and surgical procedures.
  • Clinics: Clinics are also experiencing steady growth in the adoption of sterile injectables, with a CAGR projected at 5.0% to 6.0%. Increasing use of injectables for outpatient treatments contributes to this trend.

By Key Players

The sterile injectable market is highly competitive, with prominent players focusing on product innovation, expansion of manufacturing capabilities, and strategic partnerships:
  • Pfizer: A leader in the market, offering a diverse range of sterile injectable products across multiple therapeutic areas.
  • GlaxoSmithKline: Known for its focus on vaccines and biologics in the sterile injectable category.
  • Merck & Co.: A major player specializing in oncology and immunology sterile injectables.
  • Novartis: Offers a robust portfolio of small and large molecule sterile injectable drugs.
  • Sanofi: Focuses on vaccines and biologics in the sterile injectable segment.
  • Fresenius: A key player in the generic sterile injectables market with a strong emphasis on cost-effective solutions.
  • Hikma: Known for its wide range of generic sterile injectable products.
  • Viatris: Offers a diverse portfolio of biosimilars and small-molecule sterile injectables.
  • Teva: A prominent provider of generic sterile injectable products, focusing on cost-effectiveness.
  • B. Braun: Specializes in parenteral solutions and infusion therapy sterile injectables.
  • Baxter: Known for its innovations in injectable therapies and solutions.
  • Intas Pharmaceuticals: Focuses on generic sterile injectables with a strong presence in emerging markets.
  • Sun Pharmaceutical Industries: A leading provider of generic and branded sterile injectables globally.

By Region

The sterile injectable market shows regional variations in growth rates and adoption patterns:
  • North America: North America holds the largest share, accounting for an estimated 35% to 40% of the market, supported by advanced healthcare infrastructure and high adoption of biologics. The region is expected to grow at a CAGR of 6.0% to 7.0%.
  • Europe: Europe contributes 25% to 30% of the market share, driven by strong regulatory support for sterile injectables and a focus on biosimilars. The CAGR for this region is projected at 5.5% to 6.5%.
  • Asia-Pacific: The Asia-Pacific region is expected to grow at a rapid pace, with a CAGR of 7.0% to 8.5%, fueled by increasing healthcare spending and expanding pharmaceutical manufacturing capabilities in countries like India and China.
  • Latin America: This region is anticipated to grow at a moderate CAGR of 4.5% to 6.0%, driven by improving healthcare infrastructure and rising demand for cost-effective generic injectables.
  • Middle East & Africa: The Middle East & Africa region is expected to experience steady growth, with a projected CAGR of 4.0% to 5.5%, supported by increased government investments in healthcare.

Segment Forecasts (2025-2030)

Growth in Key Segments

  • Small Molecules: Continued demand for cost-effective and widely used small-molecule injectables is expected to drive steady growth in this segment, with a projected CAGR of 5.0% to 6.5%.
  • Large Molecules: The increasing use of biologics and biosimilars for targeted therapies will support strong growth in the large molecule segment, with a projected CAGR of 6.5% to 8.0%.

Regional Insights

North America and Europe will continue to dominate the market, supported by strong healthcare infrastructure and regulatory frameworks. However, Asia-Pacific is expected to emerge as the fastest-growing region, driven by rising investments in healthcare and pharmaceutical manufacturing.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Sterile Injectable Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Sterile Injectable Market in North America (2020-2030)
8.1 Sterile Injectable Market Size
8.2 Sterile Injectable Market by End Use
8.3 Competition by Players/Suppliers
8.4 Sterile Injectable Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Sterile Injectable Market in South America (2020-2030)
9.1 Sterile Injectable Market Size
9.2 Sterile Injectable Market by End Use
9.3 Competition by Players/Suppliers
9.4 Sterile Injectable Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Sterile Injectable Market in Asia & Pacific (2020-2030)
10.1 Sterile Injectable Market Size
10.2 Sterile Injectable Market by End Use
10.3 Competition by Players/Suppliers
10.4 Sterile Injectable Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Sterile Injectable Market in Europe (2020-2030)
11.1 Sterile Injectable Market Size
11.2 Sterile Injectable Market by End Use
11.3 Competition by Players/Suppliers
11.4 Sterile Injectable Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Sterile Injectable Market in MEA (2020-2030)
12.1 Sterile Injectable Market Size
12.2 Sterile Injectable Market by End Use
12.3 Competition by Players/Suppliers
12.4 Sterile Injectable Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Sterile Injectable Market (2020-2025)
13.1 Sterile Injectable Market Size
13.2 Sterile Injectable Market by End Use
13.3 Competition by Players/Suppliers
13.4 Sterile Injectable Market Size by Type
Chapter 14 Global Sterile Injectable Market Forecast (2025-2030)
14.1 Sterile Injectable Market Size Forecast
14.2 Sterile Injectable Application Forecast
14.3 Competition by Players/Suppliers
14.4 Sterile Injectable Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Sterile Injectable Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.2 GlaxoSmithKline
15.2.1 Company Profile
15.2.2 Main Business and Sterile Injectable Information
15.2.3 SWOT Analysis of GlaxoSmithKline
15.2.4 GlaxoSmithKline Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.3 Merck& Co.
15.3.1 Company Profile
15.3.2 Main Business and Sterile Injectable Information
15.3.3 SWOT Analysis of Merck& Co.
15.3.4 Merck& Co. Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.4 Novartis
15.4.1 Company Profile
15.4.2 Main Business and Sterile Injectable Information
15.4.3 SWOT Analysis of Novartis
15.4.4 Novartis Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.5 Sanofi
15.5.1 Company Profile
15.5.2 Main Business and Sterile Injectable Information
15.5.3 SWOT Analysis of Sanofi
15.5.4 Sanofi Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.6 Fresenius
15.6.1 Company Profile
15.6.2 Main Business and Sterile Injectable Information
15.6.3 SWOT Analysis of Fresenius
15.6.4 Fresenius Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.7 Hikma
15.7.1 Company Profile
15.7.2 Main Business and Sterile Injectable Information
15.7.3 SWOT Analysis of Hikma
15.7.4 Hikma Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.8 Viatris
15.8.1 Company Profile
15.8.2 Main Business and Sterile Injectable Information
15.8.3 SWOT Analysis of Viatris
15.8.4 Viatris Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.9 Teva
15.9.1 Company Profile
15.9.2 Main Business and Sterile Injectable Information
15.9.3 SWOT Analysis of Teva
15.9.4 Teva Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.10 B. Braun
15.10.1 Company Profile
15.10.2 Main Business and Sterile Injectable Information
15.10.3 SWOT Analysis of B. Braun
15.10.4 B. Braun Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.11 Baxter
15.11.1 Company Profile
15.11.2 Main Business and Sterile Injectable Information
15.11.3 SWOT Analysis of Baxter
15.11.4 Baxter Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.12 Intas Pharmaceuticals
15.12.1 Company Profile
15.12.2 Main Business and Sterile Injectable Information
15.12.3 SWOT Analysis of Intas Pharmaceuticals
15.12.4 Intas Pharmaceuticals Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
15.13 Sun Pharmaceutical Industries
15.13.1 Company Profile
15.13.2 Main Business and Sterile Injectable Information
15.13.3 SWOT Analysis of Sun Pharmaceutical Industries
15.13.4 Sun Pharmaceutical Industries Sterile Injectable Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Sterile Injectable Report
Table Data Sources of Sterile Injectable Report
Table Major Assumptions of Sterile Injectable Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Sterile Injectable Picture
Table Sterile Injectable Classification
Table Sterile Injectable Applications
Table Drivers of Sterile Injectable Market
Table Restraints of Sterile Injectable Market
Table Opportunities of Sterile Injectable Market
Table Threats of Sterile Injectable Market
Table COVID-19 Impact For Sterile Injectable Market
Table Raw Materials Suppliers
Table Different Production Methods of Sterile Injectable
Table Cost Structure Analysis of Sterile Injectable
Table Key End Users
Table Latest News of Sterile Injectable Market
Table Merger and Acquisition
Table Planned/Future Project of Sterile Injectable Market
Table Policy of Sterile Injectable Market
Table 2020-2030 North America Sterile Injectable Market Size
Figure 2020-2030 North America Sterile Injectable Market Size and CAGR
Table 2020-2030 North America Sterile Injectable Market Size by Application
Table 2020-2025 North America Sterile Injectable Key Players Revenue
Table 2020-2025 North America Sterile Injectable Key Players Market Share
Table 2020-2030 North America Sterile Injectable Market Size by Type
Table 2020-2030 United States Sterile Injectable Market Size
Table 2020-2030 Canada Sterile Injectable Market Size
Table 2020-2030 Mexico Sterile Injectable Market Size
Table 2020-2030 South America Sterile Injectable Market Size
Figure 2020-2030 South America Sterile Injectable Market Size and CAGR
Table 2020-2030 South America Sterile Injectable Market Size by Application
Table 2020-2025 South America Sterile Injectable Key Players Revenue
Table 2020-2025 South America Sterile Injectable Key Players Market Share
Table 2020-2030 South America Sterile Injectable Market Size by Type
Table 2020-2030 Brazil Sterile Injectable Market Size
Table 2020-2030 Argentina Sterile Injectable Market Size
Table 2020-2030 Chile Sterile Injectable Market Size
Table 2020-2030 Peru Sterile Injectable Market Size
Table 2020-2030 Asia & Pacific Sterile Injectable Market Size
Figure 2020-2030 Asia & Pacific Sterile Injectable Market Size and CAGR
Table 2020-2030 Asia & Pacific Sterile Injectable Market Size by Application
Table 2020-2025 Asia & Pacific Sterile Injectable Key Players Revenue
Table 2020-2025 Asia & Pacific Sterile Injectable Key Players Market Share
Table 2020-2030 Asia & Pacific Sterile Injectable Market Size by Type
Table 2020-2030 China Sterile Injectable Market Size
Table 2020-2030 India Sterile Injectable Market Size
Table 2020-2030 Japan Sterile Injectable Market Size
Table 2020-2030 South Korea Sterile Injectable Market Size
Table 2020-2030 Southeast Asia Sterile Injectable Market Size
Table 2020-2030 Australia Sterile Injectable Market Size
Table 2020-2030 Europe Sterile Injectable Market Size
Figure 2020-2030 Europe Sterile Injectable Market Size and CAGR
Table 2020-2030 Europe Sterile Injectable Market Size by Application
Table 2020-2025 Europe Sterile Injectable Key Players Revenue
Table 2020-2025 Europe Sterile Injectable Key Players Market Share
Table 2020-2030 Europe Sterile Injectable Market Size by Type
Table 2020-2030 Germany Sterile Injectable Market Size
Table 2020-2030 France Sterile Injectable Market Size
Table 2020-2030 United Kingdom Sterile Injectable Market Size
Table 2020-2030 Italy Sterile Injectable Market Size
Table 2020-2030 Spain Sterile Injectable Market Size
Table 2020-2030 Belgium Sterile Injectable Market Size
Table 2020-2030 Netherlands Sterile Injectable Market Size
Table 2020-2030 Austria Sterile Injectable Market Size
Table 2020-2030 Poland Sterile Injectable Market Size
Table 2020-2030 Russia Sterile Injectable Market Size
Table 2020-2030 MEA Sterile Injectable Market Size
Figure 2020-2030 MEA Sterile Injectable Market Size and CAGR
Table 2020-2030 MEA Sterile Injectable Market Size by Application
Table 2020-2025 MEA Sterile Injectable Key Players Revenue
Table 2020-2025 MEA Sterile Injectable Key Players Market Share
Table 2020-2030 MEA Sterile Injectable Market Size by Type
Table 2020-2030 Egypt Sterile Injectable Market Size
Table 2020-2030 Israel Sterile Injectable Market Size
Table 2020-2030 South Africa Sterile Injectable Market Size
Table 2020-2030 Gulf Cooperation Council Countries Sterile Injectable Market Size
Table 2020-2030 Turkey Sterile Injectable Market Size
Table 2020-2025 Global Sterile Injectable Market Size by Region
Table 2020-2025 Global Sterile Injectable Market Size Share by Region
Table 2020-2025 Global Sterile Injectable Market Size by Application
Table 2020-2025 Global Sterile Injectable Market Share by Application
Table 2020-2025 Global Sterile Injectable Key Vendors Revenue
Figure 2020-2025 Global Sterile Injectable Market Size and Growth Rate
Table 2020-2025 Global Sterile Injectable Key Vendors Market Share
Table 2020-2025 Global Sterile Injectable Market Size by Type
Table 2020-2025 Global Sterile Injectable Market Share by Type
Table 2025-2030 Global Sterile Injectable Market Size by Region
Table 2025-2030 Global Sterile Injectable Market Size Share by Region
Table 2025-2030 Global Sterile Injectable Market Size by Application
Table 2025-2030 Global Sterile Injectable Market Share by Application
Table 2025-2030 Global Sterile Injectable Key Vendors Revenue
Figure 2025-2030 Global Sterile Injectable Market Size and Growth Rate
Table 2025-2030 Global Sterile Injectable Key Vendors Market Share
Table 2025-2030 Global Sterile Injectable Market Size by Type
Table 2025-2030 Sterile Injectable Global Market Share by Type

Companies Mentioned

  • Pfizer
  • GlaxoSmithKline
  • Merck& Co.
  • Novartis
  • Sanofi
  • Fresenius
  • Hikma
  • Viatris
  • Teva
  • B. Braun
  • Baxter
  • Intas Pharmaceuticals
  • Sun Pharmaceutical Industries